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Summary T lymphocytes play a primary role in recovery from viral infections and in antiviral immunity. Although viral-specific CD8 + and CD4 + T ceils have been shown to be able to lyse vitally infected targets in vitro and promote recovery from lethal infection in vivo, the role of CD4 + T lymphocytes and their mechanism(s) of action in viral immunity are not well understood. The ability to further dissect the role that CD4 + T cells play in the immune response to a number of pathogens has been greatly enhanced by evidence for more extensive heterogeneity among the CD4 + T lymphocytes. To further examine the role of CD4 + T cells in the immune response to influenza infection, we have generated influenza virus-specific CD4 + T cell clones from influenza-primed BALB/c mice with differential cytokine secretion profiles that are defined as T helper type I (Thl) clones by the production of interleukin 2 (IL-2) and interferon 3' (IFN-3'), or as Th2 dunes by the production of IL-4, IL-5, and IL-10. Our studies have revealed that Thl clones are cytolytic in vitro and protective against lethal challenge with virus in vivo, whereas Th2 clones are noncytolytic and not protective. Upon further evaluation of these donal populations we have shown that not only are the Th2 clones nonprotective, but that pulmonary pathology is exacerbated as compared with control mice as evidenced by delayed viral clearance and massive pulmonary eosinophilia. These data suggest that virus-specific CD4 + T cells of the Th2 subset may not play a primary role in virus clearance and recovery and may lead to immune mediated potentiation of injury.
B
oth antigen-nonspecific effector mechanisms, e.g., natural killer cells, (1, 2) and antigen-specific effector mechanisms, e.g., T lymphocytes (3), play a crucial role in the host response to virus infection. Many studies over the past 20 yr have added to the understanding of the function and heterogeneity of T lymphocytes responding during virus infection. Early studies suggested that the CD4-8 + CTL is the crucial antigen-specific effector cell in the host immune response to viral infection (4) . In the influenza modal, the role that CD8 + CTLs play in the host immune response to this virus has been extensively examined (5) (6) (7) (8) (9) (10) . In early studies it was shown that CD8 § CTLs, which are restricted by class I MHC molecules, can lyse vitally infected cells and promote recovery from viral infection in vivo. In addition, IFN-3, and other cytokines with antiviral activity, e.g., TNF-/5, have been suggested to play a role in viral clearance mediated by CD8 + CTLs (10, 11) .
A number of laboratories have examined the role of the CD4+8 -T cell in host immune response to virus infection in general (3) and influenza infection in particular (12) (13) (14) (15) (16) . Results from this laboratory demonstrated that influenzaspecific CD4 + T lymphocytes can lyse vitally infected targets in vitro and eliminate infectious virus and promote recovery from lethal experimental infection when clones of these CD4 + T cells are adoptively transferred in vivo (12) . Studies involving transgenic mice homozygous for the/32-microglobulin (/3z-m) gene disruption that lack functional class I MHC and CD8 + T cells, have demonstrated that influenza A virus can be cleared from the respiratory tract of these mice, thus suggesting the role of CD4 + T cells and natural killer cells as in vivo antiviral effectors (14) . Additionally, work using athymic (nude) mice has added further evidence that influenza-specific class II-restricted T cells can promote B cell responses in vivo, and that antihemagglutinin (HA) 1 antibodies alone can mediate clearance of influenza virus (16) .
The ability to further dissect the role that CD4 + T cells 1 Abbreviations used in this paper: HA, hemagglutinin; HAU, HA units; HII~_,S, heat-inactivated I~,S; HPF, high powered fields; huK, human lecombinant; KSV, respiratory syncytial virus. play in the immune response to a number of pathogens has been greatly enhanced by evidence for more extensive heterogeneity among the CD4 + T lymphocytes (17) . Stable longterm CD4 + clones that secrete IL-2 and IFN-3, upon antigenic stimulation are classified as belonging to the Thl subset, whereas those secreting IL-4, IL-5, aM IL-10 belong to the Th2 subset. The functions of Thl aM Th2 donal populations are markedly different. Although both Thl and Th2 cells can provide help for B cell (antibody) responses, Th2 cells are more effective (18) . Thl clones preferentially induce ddayed-type hypersensitivity and macrophage activation (19) . For each of these functions, the profile of the cytokines secreted by Thl and Th2 cells are the primary predictors of the differences in effector functions of these CD4 + T cell subsets in vivo.
A number of infectious disease models have examined the differential functional role of Thl vs. Th2 T ceils. In the well described Leishmania model, Thl and Th2 ceils, aM/or their respective cytokines, have different effects on the clearance of the microorganism during experimental infection (20) (21) (22) (23) . Recent studies on experimentally induced murine acquired immunoddidency syndrome (MAIDS) have suggested that Th2 cytokines play a central role in the progression of that disease (24) . In addition, work by Clerici et al. (25) has suggested that production of Th2 cytokines by HIV positive individuals may be a sensitive marker for progression to AIDS. However, at present there is very little information on the in vivo antiviral effector activity of CD4 + T cells of the Th2 subset (26) .
In the present study we have examined a panel of influenzaspecific CD4 + clones with cytokine secretion profiles that define them as belonging to either the Thl or Th2 subset. We have found that clonal populations of influenza-specific Thl T cells are cytolytic in vitro and protective in vivo, and that Th2 clones are noncytolytic in vitro and do not promote recovery in vivo. In addition, adoptive transfer of Th2 clones lead to massive pulmonary eosinophilia in the reapients and delayed viral clearance as evidenced by elevated viral titers as compared with control infected animals. These data demonstrate in a model of acute progressive viral infection that CD4 + Th2 cells do not play a primary role in virus dearance in vivo, and that the induction of this in vivo effector activity may be detrimental to the host recovery process.
Materials and Methods
Animals. Murine pathogen-free male and female BALB/c (H2a), C57B1/6 (H-2b), and C3H (H-2 k) mice 4-6 wk of age were purchased from Taconic Farms, Inc., Germantown, NY and used at 6-9 wk of age. ) were propagated in the same manner. Determination of virus titer, expressed as hemagglutinating units (HALT), was done as previously described (27) .
Cell Lines. The A20-1.11 (H-2 J) B cell lymphoma (28) was maintained in 55% DMEM high glucose, (GIBCO BRL, Gaithersburg, MD) and 35% DMEM low glucose, (GIBCO BILL) supplemented with 10% (vol/vol) heat-inactivated fetal calf serum (HIFCS; Hyclone Laboratories, Logan, UT), 1% glutamine (GIBCO BRL), 1% nonessential amino acids (GIBCO BRL), 5 x 10-s M 2-ME, and antibiotics (10 U/ml penicillin G and 10/~g/ml streptomycin sulfate [GIBCO BILL]). The P815 (H-2 d) Ia-mastocytoma and MDCK cell line (10) were maintained in DMEM low glucose (GIBCO BRL), 10% HIFCS, 1% ghtamine, and antibiotics.
Immunization of Mice for the Generation of Th2 and ThO Clones. Details of the immunization protocol have been described dsewhere (29) . Briefly, 6-8-wk-old female BALB/c mice were immunized in the hind foot pads with a 1:1 suspension of UV-inactivated influenza A/JAP/57 (50 HAU) in phosphate-buffered saline (PBS, pH 7.3) and incomplete Freund's adjuvant (Difeo Laboratories, Detroit, MI). After 10-14 d, the animals were killed, and draining inguinal and popliteal lymph nodes were removed and processed through a tissue sieve (Bellco Ghss Inc., Vineland, NJ). For in vitro secondary bulk cultures, processed lymph node cells were washed once in serum-free medium, treated with 1,000 HAU UV-mactivated virus, and plated in 6-well plates at a density of 25 x 106 cells per well in IMDM (GIBCO BILL), 10% HIFCS, 1% glutamine, 5 x 10 -s M 2-ME, and antibiotics (complete media).
Cloned T Lymphocyte Lines. The procedures developed to establish and maintain cytolytic influenza specific bulk cultures and clones from spleens of immunized mice are described in detail risewhere (30, 31) . The procedure to isohte clones from lymph node bulks is as previously described (29) . Briefly, cloues were derived by limiting dilution in 96-well flat-bottomed phtes from day 7 in vitro secondary bulk cultures. Specifically, 0.5, 1, or 5 bulk culture cells were plated per well with 106 irradiated (2,000 rad), vitally infected (1,000 HALT), syngeneic splenocytes in complete media, plus 10 U/nil human recombinant IL-2 (huRIb2) (Biosource International, Inc., Camarillo, CA) as a source of growth factor. The clones derived using this method were restimuhted every 10-14 d with irradiated, vitally infected, syngeueic splenocytes in complete media plus 10 U/ml huRII.-2 and expanded to 6-well phtes (No. 3506; Costar Corp., Cambridge, MA) containing lOVml clone cells, 4 x 106/ml infected, irradiated, syngeneic spleen cells, and 10 U/nil huRIb2 in complete media.
Cytokine Production. Supernatants from clones were harvested 48 h after stimulation in the absence of hulLlb2, and frozen at -20~ Production of IFN-7 was assayed by ELISA as previously described with reagents provided by K. Schreiber (Washington University, St. Louis, MO) (32) . Production of R,4, IL-5, and II,10 was determined using a previously descn~gl mouse cytokine ELISA protocol 0 3, Sehy, D. W.
[PharMingen], personal communication). Briefly, the appropriate primasy mAb (anti-mouse I1,4, Ib5, or IL,10; PharMingen, San Diego, CA) was diluted to 0.5-4/lg/ml in 0.1 M NaHCO3 (pH 8.2) coating buffer, 50/~1 was added to wells of an enhanced protein binding ELISA plate (Cat. no. 25805-96, Coming Ghss Inc., Coming, NY), and the plates were sealed and incubated overnight at 4~ The phtes were then washed with PBS + 0.05% Tween 20 (Sigma Chemical Co., St. Louis, MO) twice and blocked with PBS + 10% FCS for 2 h at room temperature. After washing the plate with PBS/Tween twice, standards (IL-4, IL-5, and II.-10; PharMingen) and samples were added at 200 p.1/well and incubated overnight at 4~ The phtes were washed four times with PBS/Tween, and then 100 #1 of the appropriate diluted biotinyhted anticytokine detecting mAb was added (0.5-4 #g/ml in PBS + 10% FCS) and allowed to incubate at room temperature for 45 rain. The plates were washed six times with PBS/Tween and 100 #1 avidin-peroxidase (Sigma Chemical Co.) diluted 1:400 in PBS + 10% FCS was added and allowed to incubate at room temperature for 30 min, after which the plates were washed eight times with PBS/Tween. Within 5 min of use, ABTS substrate (150 mg 2,2'-Azino-bis(3-cthylbenzthiazoline-6-sulfonic acid) [from Sigma Chemical Co.] in 500 ml 0.1 M citric add in ddFIzO, pH 4.35) was mixed with 10/~1 H202 per 10 ml of substrate and plated 100 #l/well and allowed to develop at room temperature. ELISA plates were read at OD 405 um using an automated microplate reader (model EL 340; Bio Tek Instruments, Inc., Winooski, VT). Quantities of each cytokine (IFN~, IL.4, ID5, and Ibl0) were extrapolated from standard curves generated for each ELISA assay.
Lung Virus Titration by MDCK Cell Plaque Assay. TheMDCK cell plaque assay for titration ofhng viral titers has been described in detail dsewhere (10) . The following modifications to that protocd were made. After the lungs were homogenized and prepared according to protocol, serial dilutions from 10 -1 to 10 -s were m~de in cold PBS supplemented with 0.75% BSA, 0.1 g/l MgCh, 0.1 g/1 CaCh, and antibiotics. 50 #1 of each dilution was added to the MDCK monolayer in duplicate and incubated at room temperature for 30 min. The remainder of the procedure is as previously described. Results are expressed as the mean plaque-forming units determined by the calculation [(Number of plaques per weLl)/0.05 roll x 1/dilution factor.
Assays for Cell-mediated Cytotoxicity. The SlCr release cytotoxicity assay was carried out as previously described (27) . Briefly, 106 target cells, either A20-1.11 or P815, were either left uninfected, infected with influenza A/JAP/57 or B/Lee in the presence of SlCr for 1.5 h at 37~ Targets were then washed three times and plated 5 x 103 cells/well in 96-well, fiat-bottomed, microtiter tissue culture plates in 0.1 ml vol of RPMI + 10% HIFCS. Effector cells were added in a 0.1 ral vol of RPMI + 10% HIFCS to appropriate in quadruplicam E/T ratios ranged from 1:1 to 50:1 depending on assay. The plates were incubated at 37~ in 10% CO2 for 6 h. From each well, 0.1 ml of superuatant was removed and counted on an Isomedic Gamma Counter (ICN Biomedicals, Inc., Costa Mesa, CA). The percent specific lysis was determined as previously described (10) . SEM were always <5% of the mean value and are omitted.
Assay of CelhlarPro//feration. The prolifia~tive response of cloned T cen lines was assessed by [3H]TdR incorporation, as previously described (34) . Results are expressed as the mean cpm of quadruplicate cultures at the peak of the proliferative response (day 3 of culture). SEM were always <10% of the mean value and are omitted.
Intranasai Influenza Virus Inoculation. Intranasal inoculation of mice was performed as previously described (10) . The procedure was modified from that described by using light anesthesia from methox3dturane (Pitman-Moore, Mundelein, IL). To evaluate a dose response to intranasal virus, animals received serial 10-fold dilutions of allantoic fluid in cold PBS ranging from 10 -2 to 10 -~ and animals were watched daily for morbidity and/or mortality. LDs0 values were calculated according to a modified Spearman and Karber method (35) .
Adopti~ Transfer Procedure, Adoptive transfer of day 7 viable cloned cells was performed as previously described (10). 8-wk-old male BALB/c mice were intranasally inoculated with 10 LDs0 influenza A/JAP/57 virus and within 30 min, 107 done cells in 0.5 ml IMDM (GIBCO BRL) were injected intravenously. Control mice were injected with 0.5 ml IMDM i.v. alone. Mice were watched daily for 21 d for morbidity and/or mortality. For determination of lung viral titers and histology, mice were killed on day 4 or 5 post adoptive transfer. The lungs were then aseptically removed at the bronchi, snap-frozen in liquid nitrogen, and frozen at -70~ until used.
Histolagic Examination of Lungs. Frozen lungs harvested and described above were thawed in 10% buffered formalin and sent to American HistoLabs, Inc. (Gaithersburg, MD) where they were paraffin embedded and sectioned. Each lung specimen was stained with hemotoxylin and eosin or an ensinophil-specific stain, specifically Lennert Giemsa or Luna. Morphometry was performed to quantitate the number of eosinophils present. Sections of right lung from each group were examined under high power oil immersion (100x) with a total of 400 high powered fields (HPF) counted per mouse recipient.
Results

Generation and Characterization of CD4 + Th2 Clones.
BALB/c mice were inoculated in the hind footpad with noninfectious A/JAPAN/57 virus in incomplete Freund's adjuvant as described (Materials and Methods). Dr~inlng lymph nodes from four mice were harvested and individual lymph node ceU suspensions prepared. The lymph node calls were stimulated in vitro with noninfectious influenza virus. After 10 d, viable lymphoid cells were cloned under limiting dilutions conditions in the presence of A/JAPAN/57-infected, irradiated splenocyte stimulators in medium supplemented with 10 U/ml huILIL-2. From this cloning, thirteen stable T lymphocyte clones were isolated and characterized. All dones were CD4 + and represented a heterogeneous array of CD4 + T lymphocyte subsets including Thl, Th2, and Th0 phenotype clones (17, 36) . Clones were maintained in continuous culture as described (Material and Methods).
From this panel, two CD4 + clones, 5]34 and T5C8, were expanded for further characterization. These two clones displayed the pattern of antigen dependent lymphokine production characteristic of CD4 § Th2 T cells. Both 5B4 and T5C8 secreted IL-4, IL-5, and IL-10, but no detectable IFN-'y in response to influenza virus (Table 1) . Another CD4 + T cell done, G1, showed a typical Thl pattern with secretion of IFN-3' in response to A/JAPAN/57 virus as previously reported (12) . Neither 5B4 or T5C8 produced detectable IL-2 as described in a bioassay using a CTLL variant which is sensitive to both IL-2 and IL-4 (not shown).
Both done 5B4 and T5C8 were MHC restricted in their proliferative response to the A/JAPAN/57 virus-treated splenocyte stimtdators (Fig. I a) as has been pmdously reported for the Thl clone G1 (12) . These two Th2 clones did not proliferate in response to the antigenically unrelated type B influenza strain B/LEE (Fig. 1 a) . To determine the target influenza polypeptides recognized by these Th2 clones, the proliferative response of these clones to type A influenza virus field strains and reassortant viruses was evaluated. The Th2 (Fig. 1 b) . In contrast, clone 51M recognizes only virus strains possessing the N2 neuraminidase, suggesting that this done recognizes a conserved site on the A/JAPAN/57 neuraminidase (Pig. I b).
Both Th2 clones were tested for cytolytic activity on A/JAPAN/57-infected A20-1.11 lymphoma calls that express I-A a and I-E d molecules. Neither done lysed infected A20-1.11 cells, but as previously reported by us (12) , the G1 clone did show specific cytolytic activity on A/JAPAN/57 infected, but not uninfected A20-1.11 ceils (Fig. 2) . To further test the cytolytic potential of TSC8 and 5B4, the two Th2 clones along with G1 were examined for lectin dependent cytolytic activity (37) by coincubation of cloned T ceils with target ceils in the presence of concanavalin A (5/~g/ml final in the assay) or phytohemagglutinin-p (50 ~g/ml final in the assay). Only the cytolytic CD4 + clone G1 showed lectin-dependent cytolytic activity on uninfected target cells (data not shown).
In Vivo Antiviral Effector Activity of CD4 + Th2 Clones. To evaluate the antiviral activity of cloned Th2 T ceils in vivo, clones 5IM and T5C8 and the Thl clone G1 were adoptively ~ into lethally infected ~c BALB/c mice. As reported previously (12) , the CD4 + Thl done G1 promoted recovery from lethal A/JAPAN/57 virus infection (Fig. 3) . In contrast, neither 51M nor T5C8 were able to promote recovery from lethal infection after adoptive transfer (Hg. 3). This failure of the Th2 clones to promote recovery was repeatedly observed in four separate experiments carried out over 1 yr with cloned CD4 + T cell populations mainrained in continuous in vitro culture over that period.
In Vitr E~ector Activity and Pulmonary Virus Titers. The recovery from lethal pulmonary influenza infection mediated by adoptively transferred CD8 + and CD4 + Thl T ceils is associated with reduction in pulmonary virus titers (10, 12) . To assess the effect of the Th2 clones on virus clearance, lethally infected recipients of clones 5B4, T5C8, and the Thl done G1 were killed at days 4 and 5 post infection and T cell transfer, and pulmonary virus titers determined. As Table 2 shows, lung virus titers were decreased over 100-fold relative to controis in recipients of the CD4 + Thl clone G1. In contrast, the recipients of the Th2 clones 5B4 and T5C8 showed no decrease in pulmonary virus titers compared with control infected animals which received no cells. It is noteworthy that for recipients of either Th2 done, lung virus titers were devated relative to controls. This slight enhancement in virus levels at day 4 post infection and transfer was observed for each Th2 done in two independent experiments.
In Vivo Mo~holagic Correlates of Th2 T Cell Aaivity. Lungs
of control infected mice and recipients of the CD4 + T cell clones were subjected to gross and microscopic pathologic analysis. Grossly, at day 4 post infection, the lung of control infected mice and infected G1 recipients were well aerated with focal areas of hemorrhage and collapse. In contrast, the lungs of the Th2 done recipients showed extensive congestion and diffuse collapse (not shown).
The most striking difference in the response pattern of the Th2 done recipients was evident at the microscopic level (Fig.  4) . At day 4 post infection, lungs of control mice had histologic changes typical of early influenza pneumonitis with patchy involvement of medium and small airways, focal necrosis of respiratory epithdium, and peribronchiolar and intraalveolar infiltrate consisting of mononuclear and polymorphonudear leukocytes (Fig. 4 a) . Recipients of done G1 showed few loci of inflammation with modest evidence of perivascular accumulation of lymphoblasts in focal areas of pneumonia (Fig. 4 b) . In contrast, the lungs of SB4 and T5C8 recipients were more diffusely involved with a dense accumulation of polymorphonudear lenkocytes around vessels and airway walls (Fig. 4 c) which was not evident in sections from control or G1 recipients.
When sections of hngs from infected control and done recipients were stained with the Lennart's Giemsa or Luna stain to highlight eosinophils, extensive infiltration of the lungs of Th2 recipients by eosinophils was evident (Fig. 4  d) . Fig. 5 shows quantitative morphometry data on the frequency and density of eosinophils in 400 microscopic fields taken from sections of control and done recipients. More than 20% of fields from the lungs of Th2 recipients showed two or greater eosinophils per HPF. Sections from control or G1 recipients had <1% of rid& showing significant eosinophil accumulation.
Discussion
In this report we demonstrate that clonal populations of CD4 + T lymphocytes with different cytoldne secretion profiles have distinctly different in vivo effector activities in response to pulmonary influenza inftction. Specifically, two CD4 + dunes with a Th2 cytokine profile failed to promote recovery from lethal type A influenza infection after adoptive tramfer, whereas a CD4 + Thl done promoted recovery. Recipients of these two Th2 clones, however, did show a marked eosinophil infiltration in sections of their lungs. Also, whereas the Thl done G1 reduced pulmonary virus titcrs in infected recipients, the recipients of the two Th2 clones had slightly elevated pulmonary virus titers relative to control infected animals that received no T cells. These findings raise the possibility that in this model of experimental pulmonary virus infection, induction of a CD4 + Th2 response may lead not to recovery from infection, but rather to an immunopotentiation of viral infection and injury.
The role of CD4 + T lymphocytes in virus elimination and recovery from experimental virus infection is not completely understood (3). In the murine influenza model, early evidence suggested that induction of a CD4 + T cell response during pulmonary infection leads to an increase in pulmonary inflammation and enhanced morbidity 08). At least one -r. 1000 a.
No Cl one 100.
I
1000 i G1 (Thl ) subsequent report is in agreement with this view (13) . On the other hand, studies with donal populations of activated inthenza-specific CIM + T lymphocytes suggest that CD4 + T cells can upon adoptive transfer into infected recipients, promote virus dimlnation from the lungs and recovery (12, 39) . The findings reported here and our earlier studies (12) on the in vivo effector activity of the CD4 + Thl done G1 are consistent with this view. Also, virus elimination and recovery from experimental pulmonary influenza infection has been reported in mice lacking functional CD8 + T lymphocytes (14) . This htter finding suggests that CD4 + T lymphocytes can orchestrate recovery from influenza infection in the absence of CD8 + T lymphocytes although the m~firement for CD8 + T cells in recovery may be dependent on the virulence of the challenge virus (40).
The mechanism(s) by which CD4 + Thl T cells like the G1 done promote virus clearance and recovery from pulmonary virus infection are not well understood. Scherle et al. 0 9) have shown that adoptively transferred CIM + T cells can provide help for the production of neutralizing antiinfluenza virus antibody. This antibody response in turn l__~_s to virus dearance from the lungs of infected T cell-defident (nude) mice-Furthermore, these investigators have shown that transfer of nentt~lizing anti-HA antibody alone into infected SCID mice leads to influenza virus clearance from the lungs of these immunoddicient mice (41) . To date, we have been unable to demonstrate enhanced antibody production after transfer of either the Thl done (31 or the Th2 clones, 5134 or T5C8 into A/JAPAN/57-immunized nude nnce (Graham, M. R, and T.J. Bradale, unpublished observations). The reasons for this are not dear. Differences in the B cell response to diffegent influenza virus strains is one possible explanation for the apparent lack orb cell help observed with these clones. In the studies of Scherle et al. (39, 41) influenza viruses of the HIN1 and FI3N2 subtype were used, whereas the A/JAPAN/57 virus used in our transfer study is of the H2N2 subtype. Influenza viruses of the H2N2 subtype have been reported to be mitogenic for B cells of the H-2 a haplotype (42) . Whether virus strain differences can account for the lack of CD4 + T cell help and/or alteration in B cell function under our ~ental conditions awaits to be determined.
In addition to help for antibody responses, CD4 + T cells could promote recovery from infection by direct cytolysis of MHC class II positive virus-infected cells and/or by antigen dependent rdease of cytokines with antiviral activity. Recent evidence in the influenza model (43) suggests that an important inflammatory cytokine produced by CD4 + Thl T ceils, IFN~, may not he essential for the antiviral activity of CD4 + T cells in vivo in experimental influenza infection. The contribution of other T cell cytokines and contact dependent cytolytic activity is currently being mined.
The failure of the Th2 T cell dunes to promote virus dearance and recovery was unexpected in view of the evidence that Th2 T cells augment antibody responses (18, 44) . That the two Th2 dones were functional in vivo was evidenced by the cosinophilrich inflammatory response that they evoked in the recipient mice. Perhaps more surprising was the finding that Th2 recipients had slightly higher pulmonary virus titers than controls. This raises the possibility that the induction of a strong Th2 response during viral infection could suppress other host defense mechanisms. In view of the inhibitory role of the Th2 cytokine IL-10 on CD4 + Thl T cell induction, (45), IL-10-mediated suppression of a CD4 + Thl response could be one mechanism to account for devated virus titers in the recipients of Th2 clones.
Our findings on the in vivo effect of virus-specific Th2 T cells are similar in some respects to recent results of Alwan et al. (26) . In an experimental murine model of respiratory syncytial virus (RSV) infection, these investigators showed an cosinophil-rich exudate in bronchial lavage from gSVinfected recipients of RSV-specific CD4 + T ceils enriched for the Th2 like cytokine activity. In that model, Th2 cells both enhanced morbidity and inflammation and enhanced viral clearance after adoptive transfer (26) . Since RSV infection in mice is mild and self limited (46) , it is possible that the antiviral effect as well as the immunopathologic effect of transferred Th2 T cells may reflect the same T cell effector mechanisms operating in an otherwise self limiting disease.
It is also noteworthy that in the MAIDS murine model of immunodeficiency virus infection, the production of the Th2 cytokine IL-4 may play a central role in disease pathogenesis and progression (24) . Additionally, induction of a Th2 T cell response has also been proposed to play an important role in the pathogenesis of human HIV infection (25) .
In the current report we have used activated donal populations of virus-specific CD4 § Th2 T cells to address the in vivo role this T cell subset may play in recovery from overwhdming viral infection. In our hands Th2 T cells represent the minority of the CD4 + T cell response definable in vitro at the donal level (Grah~ra, M. B., unpublished obsm'vatiom). Recent observations by Carding et al. (47) suggest a more complicated pattern of T cell responses to virus infection in vivo. These investigators reported that during experimental pulmonary influenza infection, both Thl and Th2 cytokines are activated in the lung as determined by cytokine gene transcription. It is likely that the CD4 + T cell response during viral infiction reflects a balance between antiviral effector mechanisms and inhibitory or regulatory mechanisms with no direct antiviral activity.
In conclusion our data suggest that during acute infection with a lyric virus, such as type A influenza, CD4 + T cells of the Th2 subset may not play a primary role in virus dearance and recovery. Furthermore, these data raise the possibility that the induction of a CD4 + T cell response against a lytic virus like influenza could lead to immune-mediated potentiation of injury. It will be important to determine the extent to which CD4 + Th2 T cells contribute to immune mediated pathology during viral infection and the mechanisms by which Th2 T cells produce injury.
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